CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-07 | Huizenga Theodore Alan SVP, Controller and PAO | Exercise or conversion · Stock Option | −4,000 | 8,000 | ||
| 2021-01-04 | KAKKIS EMIL D President & CEO | Sale | −30,000 | $136.90 | $4.1M | 2,329,741 |
| 2020-11-02 | KAKKIS EMIL D President & CEO | Sale | −30,000 | $96.82 | $2.9M | 2,359,741 |
| 2020-10-30 | Parschauer Karah Herdman EVP and General Counsel | Exercise or conversion | +9,903 | $54.50 | $540K | 33,871 |
| 2020-10-30 | Parschauer Karah Herdman EVP and General Counsel | Sale | −9,903 | $100.12 | $991K | 24,061 |
| 2020-10-30 | Parschauer Karah Herdman EVP and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −9,903 | 25,000 | ||
| 2020-10-28 | Parschauer Karah Herdman EVP and General Counsel | Exercise or conversion | +97 | $54.50 | $5K | 24,065 |
| 2020-10-28 | Parschauer Karah Herdman EVP and General Counsel | Sale | −97 | $100.00 | $10K | 23,968 |
| 2020-10-28 | Parschauer Karah Herdman EVP and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −97 | 34,903 | ||
| 2020-10-14 | KAKKIS EMIL D President & CEO | Shares withheld for taxes | −852 | $92.69 | $79K | 610,189 |
| 2020-10-14 | Bedrosian Camille L EVP and Chief Medical Officer | Sale | −262 | $88.00 | $23K | 35,789 |
| 2020-10-14 | Parschauer Karah Herdman EVP and General Counsel | Sale | −325 | $88.00 | $29K | 23,968 |
| 2020-10-14 | Kassberg Thomas Richard CBO & EVP | Sale | −262 | $87.98 | $23K | 101,478 |
| 2020-10-14 | Harris Erik EVP & Chief Commercial Officer | Sale | −220 | $88.00 | $19K | 23,370 |
| 2020-10-14 | Pinion John Richard | Sale | −262 | $88.00 | $23K | 46,299 |
| 2020-10-14 | Huang Dennis Karl EVP & Chief Tech Ops Officer | Sale | −262 | $88.00 | $23K | 34,699 |
| 2020-10-14 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −146 | $87.98 | $13K | 16,436 |
| 2020-10-14 | Sharp Shalini EVP, Finance | Sale | −375 | $87.99 | $33K | 97,812 |
| 2020-10-12 | Pinion John Richard | Sale | −2,780 | $94.47 | $263K | 46,561 |
| 2020-10-12 | Dier Mardi CFO & Executive Vice President | Grant or award | +40,000 | 40,000 |
Page 23 of 32 · 632 trades